Bayer Wins First Global Approval for Stroke Prevention Drug in China
Bayer said China authorized the launch of its drug to prevent recurrent stroke, marking the first global approval for a new class of medicines.
By Adria CalatayudBayer said it received regulatory authorization to launch a new drug to prevent recurrent stroke in China, winning the first global approval for a new class of medicines.The German pharmaceutical group said the decision from China's National Medical Products Administration hands i…